Literature DB >> 19279532

Increased serum CA-125 levels in patients with lung cancer post thoracotomy.

Geila Ribeiro Nuñez1, Cristina Ito, Auro Del Giglio.   

Abstract

Cancer antigen (CA)-125 is a useful tumor marker for the follow up of ovarian and lung cancer. It is a sensitive, but not specific, tumor marker. Increased serum CA-125 levels have already been described in a number of benign and malignant diseases. We report two cases of increased serum CA-125 levels status post thoracotomy for resection of an early stage lung tumor that regressed spontaneously 3 and 8 months following surgery. Serum CA-125 levels may increase after thoracotomy, unrelated to tumor recurrence. Therefore, CA-125 levels obtained postoperatively should be interpreted with caution.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19279532     DOI: 10.1097/SMJ.0b013e31819b9a8f

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

1.  Combining multiple serum biomarkers in tumor diagnosis: A clinical assessment.

Authors:  Xin Li; Jun Lu; Hui Ren; Tianjun Chen; Lin Gao; Ligai DI; Zhucui Song; Ying Zhang; Tian Yang; Asmitananda Thakur; Shu-Feng Zhou; Yanhai Yin; Mingwei Chen
Journal:  Mol Clin Oncol       Date:  2012-09-19

2.  Prognostic value of tumor markers, NSE, CA125 and SCC, in operable NSCLC Patients.

Authors:  Dangfan Yu; Kaiqi Du; Taifeng Liu; Guojun Chen
Journal:  Int J Mol Sci       Date:  2013-05-27       Impact factor: 5.923

3.  Decreased levels of serum cytokeratin 19 fragment CYFRA 21-1 predict objective response to chemotherapy in patients with non-small cell lung cancer.

Authors:  Li Pang; Jing Wang; Yanwen Jiang; Liangan Chen
Journal:  Exp Ther Med       Date:  2013-06-20       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.